Intellectual Property India Publishes Patent Application for 7-Benzyl-4-(2-Methylbenzyl)-2,4,6,7,8,9-Hexahydroimidazo [1,2-A]pyrido[3,4-E]pyrimidin-5(1h)-One, Analogs And Salts Thereof And Their Use In Therapy

MUMBAI, India, Sept. 22 -- Intellectual Property India has published a patent application (202418000195 A) filed by Oncoceutics Inc. on January 02, 2024, for 7-Benzyl-4-(2-Methylbenzyl)-2,4,6,7,8,9-Hexahydroimidazo [1,2-A]pyrido[3,4-E]pyrimidin-5(1h)-One, Analogs And Salts Thereof And Their Use In Therapy.

Inventors include Stogniew, Martin; Allen, Joshua E.; Pottorf, Richard S.; Nallaganchu, Bhaskara Rao; Olson, Gary L.; and Sun, Yanjun Filed On.

The application for the patent was published on September 18, 2026, under issue no. 38/2026.

Abstract: This disclosure relates to methods of treatment using compound ( 1) or analogs thereof, and pharmaceutically acceptable salts thereof. Also disclosed are compounds of formula ( 1 0): as defined in the specification, and pharmaceutically acceptable salts thereof, as well as pharmaceutical compositions comprising the same. Methods of treatment, such as for cancer, are provided that comprise administering the compounds and their salts to a subject in need of such treatment.

Disclaimer: Curated by HT Syndication.